National Pharmaceutical Pricing Authority

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
National Pharmaceutical Pricing Authority
Agency overview
Formed August 29, 1997 (1997-08-29)
Jurisdiction India
Headquarters 3rd/5th Floor, YMCA Cultural Center Building 1, Jai Singh Road, New Delhi, India
Agency executive
  • Bhupendra Singh, IAS, Chairman
Parent department Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers
Website nppaindia.nic.in

The National Pharmaceutical Pricing Authority (NPPA) is a government regulatory agency that controls the prices of pharmaceutical drugs in India.[1]It was formed on 29 August 1997.

Drug Price Control Orders[edit]

The NPPA regularly publishes lists of medicines and their maximum ceiling prices.The latest DPCO was released in 2013 which has a list of 384 drugs.[2][3][4][5][6][7] On 4 December 2017, it was announced a Multi-disciplinary committee of experts for consultation on matters pertaining to implementation of drug price control order (DPCO) including technicalities involved in pricing and new launches will setup and It will have member secretary of National Pharmaceutical Pricing authority (NPPA) as its convener.

Functions[edit]

  • To implement and enforce the provisions of the Drugs (Prices Control) Order in accordance with the powers delegated to it.
  • To deal with all legal matters arising out of the decisions of the Authority.
  • To monitor the availability of drugs, identify shortages, if any, and to take remedial steps.
  • To collect/ maintain data on production, exports and imports, market share of individual companies, profitability of companies etc, for bulk drugs and formulations.
  • To undertake and/ or sponsor relevant studies in respect of pricing of drugs/ pharmaceuticals.
  • To recruit/ appoint the officers and other staff members of the Authority, as per rules and procedures laid down by the Government.
  • To render advice to the Central Government on changes/ revisions in the drug policy.[8]
  • To render assistance to the Central Government in the parliamentary matters relating to the drug pricing.[9]

References[edit]

  1. ^ "Regulator may permit rejig of pharma packaging cost". Business Standard. 28 May 2012. Retrieved 20 July 2014. 
  2. ^ V, NALINAKANTHI (2014-09-29). "All you wanted to know about: DPCO". The Hindu Business Line. Retrieved 2017-10-29. 
  3. ^ "NOTIFIED PRICES OF BULK DRUGS AS SPECIFIED IN FIRST SCHEDULE OF DPCO,". www.nppaindia.nic.in. Retrieved 2017-10-29. 
  4. ^ "NOTIFIED PRICES OF BULK DRUGS AS SPECIFIED IN FIRST SCHEDULE OF DPCO,". www.nppaindia.nic.in. Retrieved 2017-10-29. 
  5. ^ "NOTIFIED PRICES OF BULK DRUGS AS SPECIFIED IN FIRST SCHEDULE OF DPCO,". www.nppaindia.nic.in. Retrieved 2017-10-29. 
  6. ^ "National Pharmaceutical Pricing Authority". www.nppaindia.nic.in. Retrieved 2017-10-29. 
  7. ^ "DPCO/NPPA | Department of Pharmaceuticals". pharmaceuticals.gov.in. Retrieved 2017-10-29. 
  8. ^ "Official National Pharmaceutical Pricing Authority". 
  9. ^ "National Pharmaceutical Pricing Authority (NPPA)". Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. Archived from the original on 28 July 2014. Retrieved 20 July 2014. 

http://nppaindia.nic.in/wh-new-2018/wh-new-07-2018.html NPPA has fixed/revised ceiling prices/retail prices of 869 formulations under Drugs (Prices Control) Order, 2013 in related Notification /order dated 02.04.2018."

External links[edit]